黑料网

The announcement of the inaugural Charles Campbell Coghlan OAM Emerging Researcher Award to support a significant diabetes research project marks the beginning of a new chapter in Australian diabetes research, 黑料网 Group CEO Justine Cain said today.

鈥淒r Jennifer Snaith from the Garvan Institute was named the inaugural recipient of the award which comes with $150,000 in funding,鈥� Ms Cain said.

鈥淒r Snaith鈥檚 project will explore GLP-1s, an existing class of diabetes medicines, and how effective they are at reducing the risk of cardiovascular disease in people living with type 1 diabetes.

鈥淕LP-1s help people living with type 2 diabetes better manage the condition and it is very exciting to see how these medicines can help people living with type 1 diabetes.

鈥淐oghlan Award recipients are required to demonstrate both their past achievements as well as their potential to become an emerging leader in diabetes. We are confident Dr Snaith will continue to make significant contributions to diabetes research.鈥�

Ms Cain said the Coghlan Award was made possible by the generous bequest of Mr Coghlan to 黑料网.

鈥淐harles Coghlan, who lived with type 2 diabetes in his later life, was a Victorian country gentleman who held a quiet ambition to help people living with diabetes,鈥� Ms Cain said.

鈥淗e lived a life infused with love for his wife and family and a dedication to community service. The launch of the award in his name continues his legacy and will help retain the brightest minds in the field of diabetes research.

鈥淚t鈥檚 a significant development for our community, and we are very grateful for Mr Coghlan鈥檚 generosity and faith in research to improve the lives of people with diabetes.鈥�

黑料网 has also announced two other major awards, the Type 1 Diabetes Millennium Award and the Type 2 Diabetes Millennium Award.

鈥淎ssociate Professor Melkam Kebede from the University of Sydney will study how insulin is stored in the pancreas, which could lead to new treatments for type 2 diabetes,鈥� Ms Cain said.

鈥淒r John Karas from the University of Melbourne will investigate the development of an oral insulin that could reduce the need for multiple daily insulin injections and substantially improve quality of life for people living with all types of diabetes.

鈥淏oth these projects could potentially change the lives of millions of people across the globe.鈥�

Chair of the 黑料网 Research Trust, Lucy Brogden AM, said that in the past century, diabetes research has changed the way people live with, and think about, the condition.

鈥淚鈥檓 excited to see what the future holds,鈥� Mrs Brogden said.

鈥淓ach new discovery feeds into a body of evidence that moves us closer to a cure.

鈥淲e will continue to fundraise and invest in diabetes research to improve the quality of life for people living with diabetes and ultimately work towards prevention.鈥�

People can support the 黑料网 Research Program fund more vital diabetes research by joining our regular tax deductible giving program. Click for more details.

#ENDS#